LRMR icon

Larimar Therapeutics

65 hedge funds and large institutions have $120M invested in Larimar Therapeutics in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

4% less funds holding

Funds holding: 6865 (-3)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

31% less capital invested

Capital invested by funds: $174M → $120M (-$54M)

Holders
65
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$27K
Puts
$6K
Net Calls
Net Calls Change

Top Buyers

1 +$3.49M
2 +$2.43M
3 +$1.71M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.57M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.2M

Top Sellers

1 -$10.3M
2 -$4.08M
3 -$1.91M
4
Millennium Management
Millennium Management
New York
-$979K
5
FAM
Fred Alger Management
New York
-$597K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$53M
2
$8.72M
3
$8.5M
4
$5.26M
5
$4.53M
6
$4.5M
7
$4.36M
8
$4.35M
9
$3.68M
10
$2.63M
11
$2.52M
12
$2.04M
13
$1.68M
14
$1.35M
15
$1.14M
16
$1.1M
17
$998K
18
$915K
19
$881K
20
$800K
21
$697K
22
$654K
23
$600K
24
$572K
25
$431K